347993 <common-name>2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,6-dichlorophenyl)acetamide</common-name> <description>2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,6-dichlorophenyl)acetamide is a chemical compound with the formula C28H28Cl2N4O2S. With an average molecular weight of 555.50 g/mol, 2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,6-dichlorophenyl)acetamide is a heavy molecule.</description> <cas>539808-79-2</cas> <pubchem-id>5160909</pubchem-id> <chemical-formula>C28H28Cl2N4O2S</chemical-formula> <weight>555.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:51:39Z</created-at> <updated-at type="dateTime">2026-08-31T11:51:39Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=CC=C1N2C(=NN=C2SCC(=O)NC3=C(C=CC=C3Cl)Cl)COC4=CC=C(C=C4)C(C)(C)C</moldb-smiles> <moldb-formula>C28H28Cl2N4O2S</moldb-formula> <moldb-inchi>InChI=1S/C28H28Cl2N4O2S/c1-18-8-5-6-11-23(18)34-24(16-36-20-14-12-19(13-15-20)28(2,3)4)32-33-27(34)37-17-25(35)31-26-21(29)9-7-10-22(26)30/h5-15H,16-17H2,1-4H3,(H,31,35)</moldb-inchi> <moldb-inchikey>RPFGFTBJBUHWDA-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">554.1310027</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343886</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,6-dichlorophenyl)acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298329</sync-id> <structure-inchikey>RPFGFTBJBUHWDA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>404000000000800002002800000000000000000000000000000000000000000000000002200004000002002480800000000000000000000000000000000000000000400000000100000000000022000000000104000200000050000000000000010000000000000000000800000000000100000000020000000000000001000040000000800000004002000080080000000100000000000000000000000100000000001000000000080100010040000000490000000000002400000000000800000000000001000000010000400010010000002010000200000000000000008000000000000040000000000400000000010000000041000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAME B0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBBAAIAAA AAIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGQCgAAAADBAZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQRACAA AAABEQAgAAAAAQYAYAAAAAICCAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZA aAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBgAgAAAABAYAYAAA AAEDBgBgAAAAAQMGAGAAAAABAwsAAQABAmgMAgNoDAMEaAwEBWgMBQZoDAYH IAcIaAwICWgMCQpoDAoLaAwLDAAMDQANDgAODygCDhAgEBEgERJoDBITaAwT FGgMFBVoDBUWaAwWFwASGAAIGQAZGgAaGyAbHGgMHB1oDB0eaAweH2gMHyBo DB4hACEiACEjACEkAAYBaAwLB2gMFhFoDCAbaAxCBAAAAAYBBgUEAwIFCQgH CwoGEhMUFRYRBhwdHh8gGxcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:31Z</structure-indexed-at> </compound>